HEADER HYDROLASE 08-NOV-04 1XXV TITLE YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE TITLE 2 CONTAINING HEXAPEPTIDE AT TWO SITES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE YOPH; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 163-468; COMPND 5 SYNONYM: VIRULENCE PROTEIN; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR DERIVED PEPTIDE; COMPND 11 CHAIN: C, D, E, F; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA ENTEROCOLITICA; SOURCE 3 ORGANISM_TAXID: 630; SOURCE 4 GENE: YOPH, YOP51; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PT7-7; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: CHEMICALLY SYNTHESIZED BY ROBERT ZAMBONI AND MICHAEL SOURCE 13 GRESSER, MERCK FROSST, MONTREAL KEYWDS CATALYTIC DOMAIN, PHOSPHOTYROSINE-BINDING SITES, SUBSTRATE TARGETING, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.I.IVANOV,J.A.STUCKEY,H.L.SCHUBERT,M.A.SAPER,J.B.BLISKA REVDAT 4 03-APR-24 1XXV 1 SEQADV LINK REVDAT 3 14-SEP-11 1XXV 1 ATOM HET HETATM LINK REVDAT 3 2 1 SEQADV SEQRES SITE VERSN REVDAT 2 24-FEB-09 1XXV 1 VERSN REVDAT 1 22-MAR-05 1XXV 0 JRNL AUTH M.I.IVANOV,J.A.STUCKEY,H.L.SCHUBERT,M.A.SAPER,J.B.BLISKA JRNL TITL TWO SUBSTRATE-TARGETING SITES IN THE YERSINIA PROTEIN JRNL TITL 2 TYROSINE PHOSPHATASE CO-OPERATE TO PROMOTE BACTERIAL JRNL TITL 3 VIRULENCE JRNL REF MOL.MICROBIOL. V. 55 1346 2005 JRNL REFN ISSN 0950-382X JRNL PMID 15720545 JRNL DOI 10.1111/J.1365-2958.2005.04477.X REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.5 REMARK 3 NUMBER OF REFLECTIONS : 18319 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 892 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 38 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4534 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 297 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.183 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 2.138 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESTRAINED B REFINEMENT REMARK 4 REMARK 4 1XXV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1000030892. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : UCSD MARK III REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS REMARK 200 DATA SCALING SOFTWARE : SDMS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18319 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MERLOT REMARK 200 STARTING MODEL: YOPH (RESIDUES 163-468) WITH BOUND VO4 (NOT REMARK 200 SUBMITTED TO PDB) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MG/ML PROTEIN, 0.5 MM REMARK 280 PHOSPHONODIFLUORO-PHE-CONTAINING PEPTIDE IN 1 MM IMIDAZOLE. REMARK 280 PRECIPITANT: 22% POLYETHYLENE GLYCOL (PEG) 4000, 8 MM MNCL2, 0.1% REMARK 280 BETA-MERCAPTOETHANOL, 100 MM HEPES, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 163 REMARK 465 ARG A 164 REMARK 465 GLU A 165 REMARK 465 ARG A 166 REMARK 465 PRO A 167 REMARK 465 HIS A 168 REMARK 465 THR A 169 REMARK 465 SER A 170 REMARK 465 GLY A 171 REMARK 465 HIS A 172 REMARK 465 HIS A 173 REMARK 465 GLY A 174 REMARK 465 ALA A 175 REMARK 465 GLY A 176 REMARK 465 GLU A 177 REMARK 465 ALA A 178 REMARK 465 ARG A 179 REMARK 465 ALA A 180 REMARK 465 THR A 181 REMARK 465 ALA A 182 REMARK 465 PRO A 183 REMARK 465 SER A 184 REMARK 465 THR A 185 REMARK 465 VAL A 186 REMARK 465 PRO B 163 REMARK 465 ARG B 164 REMARK 465 GLU B 165 REMARK 465 ARG B 166 REMARK 465 PRO B 167 REMARK 465 HIS B 168 REMARK 465 THR B 169 REMARK 465 SER B 170 REMARK 465 GLY B 171 REMARK 465 HIS B 172 REMARK 465 HIS B 173 REMARK 465 GLY B 174 REMARK 465 ALA B 175 REMARK 465 GLY B 176 REMARK 465 GLU B 177 REMARK 465 ALA B 178 REMARK 465 ARG B 179 REMARK 465 ALA B 180 REMARK 465 THR B 181 REMARK 465 ALA B 182 REMARK 465 PRO B 183 REMARK 465 SER B 184 REMARK 465 THR B 185 REMARK 465 VAL B 186 REMARK 465 ACE C 100 REMARK 465 ASP C 101 REMARK 465 ALA C 102 REMARK 465 ACE D 0 REMARK 465 ACE E 100 REMARK 465 ASP E 101 REMARK 465 ALA E 102 REMARK 465 ACE F 0 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP E 103 CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 281 141.76 -170.09 REMARK 500 THR A 318 -112.69 -107.71 REMARK 500 ASN A 353 41.72 -104.74 REMARK 500 CYS A 403 -114.13 -117.69 REMARK 500 ASN A 424 31.05 -92.04 REMARK 500 ARG A 440 -72.53 -135.78 REMARK 500 ASN A 441 149.93 -171.74 REMARK 500 VAL A 445 78.45 78.85 REMARK 500 GLN A 446 -71.51 -71.66 REMARK 500 VAL B 281 142.51 -170.08 REMARK 500 THR B 318 -112.35 -108.41 REMARK 500 ASN B 353 41.15 -104.43 REMARK 500 CYS B 403 -114.91 -119.10 REMARK 500 ASN B 424 30.17 -92.06 REMARK 500 ARG B 440 -73.73 -135.91 REMARK 500 VAL B 445 77.80 78.50 REMARK 500 GLN B 446 -72.15 -71.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF EPIDERMAL GROWTH REMARK 800 FACTOR RECEPTOR DERIVED PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF EPIDERMAL GROWTH REMARK 800 FACTOR RECEPTOR DERIVED PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF EPIDERMAL GROWTH REMARK 800 FACTOR RECEPTOR DERIVED PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF EPIDERMAL GROWTH REMARK 800 FACTOR RECEPTOR DERIVED PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XXP RELATED DB: PDB REMARK 900 COMPANION STRUCTURE OF YOPH (RESIDUES 163-468) C403S BOUND TO A REMARK 900 PHOSPHOTYROSYL-CONTAINING HEXAPEPTIDE REMARK 900 RELATED ID: 1QZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN REMARK 900 COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE DBREF 1XXV A 163 468 UNP P15273 YOPH_YEREN 163 468 DBREF 1XXV B 163 468 UNP P15273 YOPH_YEREN 163 468 DBREF 1XXV C 101 106 PDB 1XXV 1XXV 101 106 DBREF 1XXV D 1 6 PDB 1XXV 1XXV 1 6 DBREF 1XXV E 101 106 PDB 1XXV 1XXV 101 106 DBREF 1XXV F 1 6 PDB 1XXV 1XXV 1 6 SEQADV 1XXV ARG A 235 UNP P15273 CYS 235 ENGINEERED MUTATION SEQADV 1XXV ARG B 235 UNP P15273 CYS 235 ENGINEERED MUTATION SEQRES 1 A 306 PRO ARG GLU ARG PRO HIS THR SER GLY HIS HIS GLY ALA SEQRES 2 A 306 GLY GLU ALA ARG ALA THR ALA PRO SER THR VAL SER PRO SEQRES 3 A 306 TYR GLY PRO GLU ALA ARG ALA GLU LEU SER SER ARG LEU SEQRES 4 A 306 THR THR LEU ARG ASN THR LEU ALA PRO ALA THR ASN ASP SEQRES 5 A 306 PRO ARG TYR LEU GLN ALA CYS GLY GLY GLU LYS LEU ASN SEQRES 6 A 306 ARG PHE ARG ASP ILE GLN CYS ARG ARG GLN THR ALA VAL SEQRES 7 A 306 ARG ALA ASP LEU ASN ALA ASN TYR ILE GLN VAL GLY ASN SEQRES 8 A 306 THR ARG THR ILE ALA CYS GLN TYR PRO LEU GLN SER GLN SEQRES 9 A 306 LEU GLU SER HIS PHE ARG MET LEU ALA GLU ASN ARG THR SEQRES 10 A 306 PRO VAL LEU ALA VAL LEU ALA SER SER SER GLU ILE ALA SEQRES 11 A 306 ASN GLN ARG PHE GLY MET PRO ASP TYR PHE ARG GLN SER SEQRES 12 A 306 GLY THR TYR GLY SER ILE THR VAL GLU SER LYS MET THR SEQRES 13 A 306 GLN GLN VAL GLY LEU GLY ASP GLY ILE MET ALA ASP MET SEQRES 14 A 306 TYR THR LEU THR ILE ARG GLU ALA GLY GLN LYS THR ILE SEQRES 15 A 306 SER VAL PRO VAL VAL HIS VAL GLY ASN TRP PRO ASP GLN SEQRES 16 A 306 THR ALA VAL SER SER GLU VAL THR LYS ALA LEU ALA SER SEQRES 17 A 306 LEU VAL ASP GLN THR ALA GLU THR LYS ARG ASN MET TYR SEQRES 18 A 306 GLU SER LYS GLY SER SER ALA VAL ALA ASP ASP SER LYS SEQRES 19 A 306 LEU ARG PRO VAL ILE HIS CYS ARG ALA GLY VAL GLY ARG SEQRES 20 A 306 THR ALA GLN LEU ILE GLY ALA MET CYS MET ASN ASP SER SEQRES 21 A 306 ARG ASN SER GLN LEU SER VAL GLU ASP MET VAL SER GLN SEQRES 22 A 306 MET ARG VAL GLN ARG ASN GLY ILE MET VAL GLN LYS ASP SEQRES 23 A 306 GLU GLN LEU ASP VAL LEU ILE LYS LEU ALA GLU GLY GLN SEQRES 24 A 306 GLY ARG PRO LEU LEU ASN SER SEQRES 1 B 306 PRO ARG GLU ARG PRO HIS THR SER GLY HIS HIS GLY ALA SEQRES 2 B 306 GLY GLU ALA ARG ALA THR ALA PRO SER THR VAL SER PRO SEQRES 3 B 306 TYR GLY PRO GLU ALA ARG ALA GLU LEU SER SER ARG LEU SEQRES 4 B 306 THR THR LEU ARG ASN THR LEU ALA PRO ALA THR ASN ASP SEQRES 5 B 306 PRO ARG TYR LEU GLN ALA CYS GLY GLY GLU LYS LEU ASN SEQRES 6 B 306 ARG PHE ARG ASP ILE GLN CYS ARG ARG GLN THR ALA VAL SEQRES 7 B 306 ARG ALA ASP LEU ASN ALA ASN TYR ILE GLN VAL GLY ASN SEQRES 8 B 306 THR ARG THR ILE ALA CYS GLN TYR PRO LEU GLN SER GLN SEQRES 9 B 306 LEU GLU SER HIS PHE ARG MET LEU ALA GLU ASN ARG THR SEQRES 10 B 306 PRO VAL LEU ALA VAL LEU ALA SER SER SER GLU ILE ALA SEQRES 11 B 306 ASN GLN ARG PHE GLY MET PRO ASP TYR PHE ARG GLN SER SEQRES 12 B 306 GLY THR TYR GLY SER ILE THR VAL GLU SER LYS MET THR SEQRES 13 B 306 GLN GLN VAL GLY LEU GLY ASP GLY ILE MET ALA ASP MET SEQRES 14 B 306 TYR THR LEU THR ILE ARG GLU ALA GLY GLN LYS THR ILE SEQRES 15 B 306 SER VAL PRO VAL VAL HIS VAL GLY ASN TRP PRO ASP GLN SEQRES 16 B 306 THR ALA VAL SER SER GLU VAL THR LYS ALA LEU ALA SER SEQRES 17 B 306 LEU VAL ASP GLN THR ALA GLU THR LYS ARG ASN MET TYR SEQRES 18 B 306 GLU SER LYS GLY SER SER ALA VAL ALA ASP ASP SER LYS SEQRES 19 B 306 LEU ARG PRO VAL ILE HIS CYS ARG ALA GLY VAL GLY ARG SEQRES 20 B 306 THR ALA GLN LEU ILE GLY ALA MET CYS MET ASN ASP SER SEQRES 21 B 306 ARG ASN SER GLN LEU SER VAL GLU ASP MET VAL SER GLN SEQRES 22 B 306 MET ARG VAL GLN ARG ASN GLY ILE MET VAL GLN LYS ASP SEQRES 23 B 306 GLU GLN LEU ASP VAL LEU ILE LYS LEU ALA GLU GLY GLN SEQRES 24 B 306 GLY ARG PRO LEU LEU ASN SER SEQRES 1 C 8 ACE ASP ALA ASP GLU FTY LEU NH2 SEQRES 1 D 8 ACE ASP ALA ASP GLU FTY LEU NH2 SEQRES 1 E 8 ACE ASP ALA ASP GLU FTY LEU NH2 SEQRES 1 F 8 ACE ASP ALA ASP GLU FTY LEU NH2 MODRES 1XXV FTY C 105 TYR DEOXY-DIFLUOROMETHELENE-PHOSPHOTYROSINE MODRES 1XXV FTY D 5 TYR DEOXY-DIFLUOROMETHELENE-PHOSPHOTYROSINE MODRES 1XXV FTY E 105 TYR DEOXY-DIFLUOROMETHELENE-PHOSPHOTYROSINE MODRES 1XXV FTY F 5 TYR DEOXY-DIFLUOROMETHELENE-PHOSPHOTYROSINE HET FTY C 105 18 HET NH2 C 107 1 HET FTY D 5 18 HET NH2 D 7 1 HET FTY E 105 18 HET NH2 E 107 1 HET FTY F 5 18 HET NH2 F 7 1 HETNAM FTY DEOXY-DIFLUOROMETHELENE-PHOSPHOTYROSINE HETNAM NH2 AMINO GROUP FORMUL 3 FTY 4(C10 H12 F2 N O5 P) FORMUL 3 NH2 4(H2 N) FORMUL 7 HOH *297(H2 O) HELIX 1 1 GLY A 190 LEU A 208 1 19 HELIX 2 2 ARG A 235 ALA A 239 5 5 HELIX 3 3 LEU A 263 SER A 265 5 3 HELIX 4 4 GLN A 266 ASN A 277 1 12 HELIX 5 5 SER A 287 ASN A 293 1 7 HELIX 6 6 GLN A 294 GLY A 297 5 4 HELIX 7 7 SER A 361 LYS A 386 1 26 HELIX 8 8 GLY A 408 ASP A 421 1 14 HELIX 9 9 SER A 428 ARG A 440 1 13 HELIX 10 10 LYS A 447 GLN A 461 1 15 HELIX 11 11 GLY B 190 LEU B 208 1 19 HELIX 12 12 LEU B 263 SER B 265 5 3 HELIX 13 13 GLN B 266 ASN B 277 1 12 HELIX 14 14 SER B 287 ASN B 293 1 7 HELIX 15 15 GLN B 294 GLY B 297 5 4 HELIX 16 16 SER B 361 LYS B 386 1 26 HELIX 17 17 GLY B 408 ASP B 421 1 14 HELIX 18 18 SER B 428 ARG B 440 1 13 HELIX 19 19 LYS B 447 GLN B 461 1 15 SHEET 1 A 8 ALA A 246 VAL A 251 0 SHEET 2 A 8 THR A 254 CYS A 259 -1 O ALA A 258 N ASN A 247 SHEET 3 A 8 VAL A 400 HIS A 402 1 O ILE A 401 N ILE A 257 SHEET 4 A 8 LEU A 282 VAL A 284 1 N ALA A 283 O VAL A 400 SHEET 5 A 8 ILE A 344 VAL A 351 1 O VAL A 349 N LEU A 282 SHEET 6 A 8 ILE A 327 ARG A 337 -1 N ASP A 330 O HIS A 350 SHEET 7 A 8 ILE A 311 GLY A 324 -1 N THR A 312 O ARG A 337 SHEET 8 A 8 GLY A 306 TYR A 308 -1 N GLY A 306 O VAL A 313 SHEET 1 B 8 ALA B 246 VAL B 251 0 SHEET 2 B 8 THR B 254 CYS B 259 -1 O ALA B 258 N ASN B 247 SHEET 3 B 8 VAL B 400 HIS B 402 1 O ILE B 401 N ILE B 257 SHEET 4 B 8 LEU B 282 VAL B 284 1 N ALA B 283 O VAL B 400 SHEET 5 B 8 ILE B 344 VAL B 351 1 O VAL B 349 N LEU B 282 SHEET 6 B 8 ILE B 327 ARG B 337 -1 N ASP B 330 O HIS B 350 SHEET 7 B 8 ILE B 311 GLY B 324 -1 N THR B 318 O MET B 331 SHEET 8 B 8 GLY B 306 TYR B 308 -1 N GLY B 306 O VAL B 313 LINK C GLU C 104 N FTY C 105 1555 1555 1.33 LINK C FTY C 105 N LEU C 106 1555 1555 1.33 LINK C LEU C 106 N NH2 C 107 1555 1555 1.26 LINK C GLU D 4 N FTY D 5 1555 1555 1.33 LINK C FTY D 5 N LEU D 6 1555 1555 1.33 LINK C LEU D 6 N NH2 D 7 1555 1555 1.25 LINK C GLU E 104 N FTY E 105 1555 1555 1.33 LINK C FTY E 105 N LEU E 106 1555 1555 1.33 LINK C LEU E 106 N NH2 E 107 1555 1555 1.25 LINK C GLU F 4 N FTY F 5 1555 1555 1.32 LINK C FTY F 5 N LEU F 6 1555 1555 1.33 LINK C LEU F 6 N NH2 F 7 1555 1555 1.25 SITE 1 AC1 19 PHE A 229 ARG A 230 ASP A 231 ILE A 232 SITE 2 AC1 19 ASP A 356 GLN A 357 CYS A 403 ARG A 404 SITE 3 AC1 19 ALA A 405 GLY A 406 VAL A 407 GLY A 408 SITE 4 AC1 19 ARG A 409 GLN A 446 HOH A 632 HOH A 745 SITE 5 AC1 19 HOH B 705 NH2 C 107 HOH C 624 SITE 1 AC2 14 ARG A 278 ARG A 295 LYS A 342 THR A 343 SITE 2 AC2 14 MET A 382 LYS A 386 SER A 388 SER A 389 SITE 3 AC2 14 HOH A 774 SER B 468 NH2 D 7 HOH D 539 SITE 4 AC2 14 HOH D 540 HOH D 542 SITE 1 AC3 17 HOH A 749 PHE B 229 ARG B 230 ASP B 231 SITE 2 AC3 17 ILE B 232 ASP B 356 GLN B 357 CYS B 403 SITE 3 AC3 17 ARG B 404 ALA B 405 GLY B 406 VAL B 407 SITE 4 AC3 17 GLY B 408 ARG B 409 GLN B 446 NH2 E 107 SITE 5 AC3 17 HOH E 783 SITE 1 AC4 15 SER A 468 ARG B 278 ARG B 295 LYS B 342 SITE 2 AC4 15 THR B 343 ILE B 344 SER B 345 LYS B 386 SITE 3 AC4 15 SER B 388 SER B 389 HOH B 709 NH2 F 7 SITE 4 AC4 15 HOH F 642 HOH F 644 HOH F 818 CRYST1 54.130 47.170 71.820 104.45 115.05 89.97 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018474 -0.000010 0.008978 0.00000 SCALE2 0.000000 0.021200 0.006069 0.00000 SCALE3 0.000000 0.000000 0.015987 0.00000